Roll-call vote · 20 January 2026

Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest ***I

Amendments by the committee responsible – separate vote

Part of: 2025/0102(COD) · first reading
Adopted
For 528Against 123Abstain 10

This is the vote on Amendment 163. We record the outcome and the full roll-call below — but not the amendment’s wording: what it proposed to change isn’t in our data yet (it lives in the tabled-amendment documents, which we don’t ingest).

How the vote split

for · against · abstain

By political group

PPE168·14·0
S-D123·0·0
PFE0·78·0
ECR64·6·3
RENEW63·1·3
VERTS-ALE51·0·0
THE-LEFT37·1·1
NI19·4·3
ESN3·19·0

By country

Germany77·12·1
Italy66·7·0
France36·34·0
Spain47·6·0
Poland47·2·0
Netherlands24·6·0
Romania30·0·0
Greece15·6·0
Czechia10·9·1

Every vote cast

661 recorded positions
Download CSVShowing 1–10 of 661
Abir AL-SAHLANIRENEW · SWEFor
Adam BIELANECR · POLFor
Adam JARUBASPPE · POLFor
Adina VĂLEANPPE · ROUFor
Adnan DIBRANIS-D · SWEFor
Afroditi LATINOPOULOUPFE · GRCAgainst
Alberico GAMBINOECR · ITAFor
Aleksandar NIKOLICPFE · FRAAgainst
Alessandra MORETTIS-D · ITAFor